In a collaborative effort, TRACK-TBI and TED Investigators drafted two responses to the FDA's Request for Information on Identifying Potential Biomarkers for Qualification and Describing Contexts of Use to Address Areas Important to Drug Development. Responses on the potential of blood-based and MRI biomarkers in TBI were submitted.
To read the response on Blood-Based Biomarkers, click here.
The TBI Endpoints (TED) Initiative held its first Consensus Conference on February 2-3, 2015 at the NIH campus in Bethesda, MD. The TED Initiative, a five-year program funded by the U.S. Department of Defense, will curate and harmonize data from a variety of legacy and ongoing military, civilian, and sport TBI cohorts into a Metadataset that can be interrogated for associations between clinical, proteomic, genomic, and imaging findings that smaller individual studies were not powered or designed to find.